Urinary cytokeratin 20 as a marker for transitional cell carcinoma.
- 1 January 2000
- journal article
- bladder cancer
- Published by Elsevier in European Urology
- Vol. 37 (5) , 601-604
- https://doi.org/10.1159/000020199
Abstract
To determine if detection of cytokeratin 20 (CK20) gene expression, by reverse transcriptase-polymerase chain reaction (RT-PCR) in urine from transitional cell carcinoma (TCC) patients, can provide a new noninvasive tool for the follow-up of patients with urothelial carcinoma of the bladder.Keywords
This publication has 0 references indexed in Scilit: